Research location
Whippany
New Jersey, United States
Advertisement
Research activity in Whippany
New Jersey, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 20 trials and 20 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Whippany
20 linked trials · page 1 of 1A Study to Learn About Heart-Related Risks in Elderly Men With Advanced Prostate Cancer Treated With Enzalutamide or DarolutamideNCT07672119 · 2026-06-04 · 1 site observation
RECRUITING
An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Care in the United StatesNCT06608212 · 2024-10-09 · 1 site observation
COMPLETED
An Observational Study to Learn More About Vericiguat Treatment Patterns and Its Safety in People With Chronic Heart Failure With Reduced Ejection Fraction in Routine Medical Care in the United StatesNCT06363110 · 2024-04-10 · 1 site observation
COMPLETED
An Observational Study to Learn More About the Use of Androgen Receptor Inhibitors and How They Affect Men With Nonmetastatic Prostate Cancer in Routine Medical Care in the United StatesNCT06204302 · 2024-01-05 · 1 site observation
COMPLETED
An Observational Cohort Study to Describe and Compare the Use of Darolutamide, Enzalutamide and Apalutamide and How Well These Work in Men With Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) in Real World SettingsNCT06013475 · 2023-08-31 · 1 site observation
COMPLETED
An Observational Study Called FLAMINgO to Learn More About the Treatment Combination of Finerenone and SGLT2 Inhibitors in People With Long-term Kidney Disease (Chronic Kidney Disease) Together With Type 2 Diabetes by Using Routine Medical Care Data and Past Clinical Study ResultsNCT05640180 · 2022-11-23 · 1 site observation
COMPLETED
A Study Using Surveys to Learn More About Treatment With Steroidal Mineralocorticoid Receptor Antagonists, How They Are Used, What Side Effects They Have, and How Satisfied People Who Receive Them Are in the USNCT05407662 · 2022-11-02 · 1 site observation
COMPLETED
An Observational Study, Called ROCURS, to Learn About COVID-19 Related Outcomes in People With Cancer Who Are Treated With Tyrosine Kinase Inhibitors (TKIs) Including Regorafenib or SorafenibNCT05594147 · 2022-10-31 · 1 site observation
COMPLETED
An Observational Study, Called DEAR, to Learn More About Treatment With Darolutamide, Enzalutamide and Apalutamide in Men With Non-metastatic Castration-resistant Prostate Cancer in Real World SettingsNCT05362149 · 2022-04-04 · 1 site observation
COMPLETED
A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication CompletelyNCT05202301 · 2022-01-15 · 1 site observation
COMPLETED
US PROmyBETAapp2.0: A Study to Learn More About the Medication Usage and Patient Reported Outcomes Via the myBETAapp in Medical Care of Patients With Multiple Sclerosis Treated With BETASERON Using BETACONNECT AutoinjectorNCT04356339 · 2020-11-24 · 1 site observation
COMPLETED
A Study Using Electronic Health Information to Learn About Rivaroxaban Compared to Warfarin in Participants With Non-valvular Atrial Fibrillation (NVAF) and DiabetesNCT04509193 · 2020-08-21 · 1 site observation
COMPLETED
EPIX, a Study to Gather More Information About Characteristics of Patients and Other Factors Which May Contribute to Survival Over a Long Period of Time in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Treated With Radium-223 (Xofigo)NCT04516161 · 2020-08-03 · 1 site observation
COMPLETED
Descriptive Analysis of Clinical Outcomes in Patients With Prostate Gland Cancer, Which Spreads to Other Parts of the Body, Who Were Treated First With Novel Anti-hormone Therapy Followed by a Second Line Treatment With Novel Anti-Hormone Therapy or RadIum-223 (Xofigo).NCT03896984 · 2019-03-18 · 1 site observation
COMPLETED
Multi-academic Center Study of Xofigo PatientsNCT03419442 · 2018-12-03 · 1 site observation
COMPLETED
Study to Develop a Tool to Estimate the Kidney Function in Databases Without Laboratory DataNCT03605810 · 2018-07-15 · 1 site observation
COMPLETED
Navigant Study- Treatment Patterns in mCRPC (Metastatic Castrate Resistant Prostate Cancer )NCT02899104 · 2017-06-15 · 1 site observation
COMPLETED
Treatment Patterns in Metastatic Prostate CancerNCT02729103 · 2016-10-31 · 1 site observation
COMPLETED
A Phase 1 Study To Evaluate Escalating Doses Of A Vaccine-Based Immunotherapy Regimen For Prostate Cancer (PrCa VBIR)NCT02616185 · 2015-12-30 · 1 site observation
TERMINATED
Intimacy-Enhancing Couples' Intervention for Localized Prostate CancerNCT01982058 · 2011-08-18 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.